Funding from the Governments of Canada and Alberta will contribute to the new R&D center and GMP manufacturing facility in ...
“We are thrilled to receive this investment, which will enable us to build a cutting-edge GMP biomanufacturing facility and innovative R&D centre in Edmonton, Alberta, Canada,” said John Lewis, CEO, ...
Hosted on MSN2mon
Senores Pharmaceuticals IPO GMP: Grey market premium on fire! Over Rs 200/share gain? Last day alertSenores Pharmaceuticals IPO GMP: The three-day subscription window for Senores Pharmaceuticals Limited IPO will close tomorrow, i.e. Tuesday, December 24, 2024. On the second day, the Senores ...
WuXi Biologics passes GMP inspection by Japan PMDA for its drug substance facilities in Wuxi city: Wuxi, China Friday, February 28, 2025, 15:00 Hrs [IST] WuXi Biologics (WuXi Bio) ...
Aveo Pharmaceuticals asserts that a stop-production notice was issued due to non-compliance with GMP standards, not for ...
Hosted on MSN2mon
IPO GMP, listing date: Ventive Hospitality, Senores Pharmaceuticals to Carraro India - what grey market signals?IPO GMP, listing date: For Ventive Hospitality IPO, Senores Pharmaceuticals IPO, and Carraro India IPO listing date has been scheduled for tomorrow (Monday, December 30). IPO allotment for these ...
Symbiosis’ completion of the FDA regulatory review is expected to increase the company’s commercial-scale sterile manufacturing capabilities.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback